Actions: S.Amdt. 2111 — 112th Congress (2011-2012)All Information (Except Text)

Date All Actions
05/24/2012Amendment SA 2111, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 28 - 67. Record Vote Number: 105.
05/24/2012Amendment SA 2111 proposed by Senator Bingaman. (consideration: CR S3542-3543, S3547-3548, S3553-3554) To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive "pay-for-delay" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market.